中文 | English
Return
Total: 88 , 1/9
Show Home Prev Next End page: GO
MeSH:(Carcinoma, Renal Cell/genetics*)

1.Comprehensive analysis of the aberrantly expressed profiles of lncRNAs, miRNAs and the regulation network of the associated ceRNAs in clear cell renal cell carcinoma.

Wanting HOU ; Qiulin TANG ; Feng BI

Journal of Biomedical Engineering 2019;36(2):267-273

4.Cuproptosis-Related 4-Gene Risk Model for Predicting Immunotherapy Drug Response and Prognosis of Kidney Renal Clear Cell Carcinoma.

Jin-Shuai GUO ; Hao DING ; Peng-Yu WU ; Zi-Yi XIN ; Jian-Xin LI ; Hyon-Su JO ; Zhen-Hai MA

Chinese Medical Sciences Journal 2023;38(3):191-205

5.Establishment of a mutation prediction model for evaluating the efficacy of immunotherapy in renal carcinoma.

Cai Peng QIN ; Yu Xuan SONG ; Meng Ting DING ; Fei WANG ; Jia Xing LIN ; Wen Bo YANG ; Yi Qing DU ; Qing LI ; Shi Jun LIU ; Tao XU

Journal of Peking University(Health Sciences) 2022;54(4):663-668

6.Consensus on clinical diagnosis and treatment of fumarate hydratase-deficient renal cell carcinoma.

Chinese Journal of Surgery 2022;60(11):961-968

8.MiR-744-5p inhibits the proliferation, invasion, and migration of clear-cell renal cell carcinoma cells by targeting CCND1.

Kun Yang LEI ; Wen Jie XIE ; Ting SUN ; Yi Fu LIU ; Xu WANG

Journal of Southern Medical University 2022;42(5):712-717

10.Clinical analysis in diagnosis and treatment of 11 patients with hereditary renal cell carcinoma.

Da-xin GONG ; Xia WANG ; Ze-liang LI ; Yuan-jun JIANG ; Zhi-xi SUN ; Chui-ze KONG

Chinese Journal of Surgery 2006;44(14):963-965

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 88 , 1/9 Show Home Prev Next End page: GO